Heidbreder, Anna
Kunz, Dieter
Young, Pitt
Benes, Heike
Chalet, Francois-Xavier
Vaillant, Cedric
Kaskel, Peter
Fietze, Ingo
Schöbel, Christoph
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Accepted: 20 March 2024
First Online: 4 June 2024
Declarations
:
: A. Heidbreder declares that she has received payments or honoraria for lectures, presentations, etc. from Jazz Pharmaceuticals Ltd. and UCB, travel support from Jazz Pharmaceuticals, and has participated in a data safety monitoring panel of Desitin and Idorsia Pharmaceuticals Ltd. outside the submitted work. D. Kunz declares that he has received research support and other benefits from Idorsia Pharmaceuticals Ltd. in Allschwil, BL, Switzerland, outside the submitted work. P. Young, an employee of the Medical Park Hospital Group, declares that he has received lecture fees from Bioprojet, Idorsia Pharmaceuticals Ltd., Jazz Pharmaceuticals, Medice, Löwenstein Medical, Somnomedic, Amiczus, and Sanofi outside the submitted work. He has also received consulting fees from Sanofi, Medice, Idorsia Pharmaceuticals Ltd., and Jazz Pharmaceuticals outside the submitted work. H. Benes, an employee of the Somni Bene Institute for Medical Research and Sleep Medicine Schwerin GmbH, Schwerin, Germany, is head of the Sleep Laboratory Schwerin, a specialized sleep laboratory for neuropsychiatric disorders, which has received financial research support for conducting clinical trials from Idorsia Pharmaceuticals Ltd. outside the submitted work. F.-X. Chalet and C. Vaillant are employees of Idorsia Pharmaceuticals Ltd. P. Kaskel is an employee of Idorsia Pharmaceuticals Germany GmbH. I. Fietze declares that he has received consultancy fees from Bayer, Bioprojet, Idorsia Pharmaceuticals Ltd, Jazz Pharmaceuticals, STADA, and Takeda outside the submitted work. C. Schöbel declares that he has received institutional and other support from AstraZeneca, Novartis and ResMed, other support from Berlin Chemie, Bristol-Myers Squibb, Idorsia Pharmaceuticals Ltd., Löwenstein Medical and novamed as well as Jazz Pharmaceuticals, Sleepiz, Mementor DE, outside the submitted work.
: No human or animal studies were conducted by the authors for this paper. The NHWS 2020 protocol and questionnaire were reviewed by the Pearl Institutional Review Board (Indianapolis, IN, USA; 19-KANT-204) and received “exemption status study sample” status [].